{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:29:06Z","timestamp":1766428146355,"version":"3.37.3"},"reference-count":112,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103671"],"award-info":[{"award-number":["82103671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>It is documented that osteoarthritis can promote the progression of breast\ncancer (BC).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aims to search for the essential genes associated with breast cancer (BC) and\nosteoarthritis (OA), explore the relationship between epithelial-mesenchymal transition (EMT)-\nrelated genes and the two diseases, and identify the candidate drugs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The genes related to both BC and OA were determined by text mining. Protein-protein\nInteraction (PPI) analysis was carried out, and as a result, the exported genes were found to be related\nto EMT. PPI and the correlation of mRNA of these genes were also analyzed. Different kinds\nof enrichment analyses were performed on these genes. A prognostic analysis was performed on\nthese genes for examining their expression levels at different pathological stages, in different tissues,\nand in different immune cells. Drug\u2013gene interaction database was employed for potential\ndrug discovery.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total number of 1422 genes were identified as common to BC and OA and 58 genes\nwere found to be related to EMT. We found that HDAC2 and TGFBR1 were significantly poor in\noverall survival. High expression of HDAC2 plays a vital role in the increase of pathological stages.\nFour immune cells might play a role in this process. Fifty-seven drugs were identified that\ncould potentially have therapeutic effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>EMT may be one of the mechanisms by which OA affects BC. Using the drugs can\nhave potential therapeutic effects, which may benefit patients with both diseases and broaden the\nindications for drug use.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207326666230508113036","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:10:32Z","timestamp":1683609032000},"page":"238-255","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Searching for Essential Genes and Targeted Drugs Common to Breast\nCancer and Osteoarthritis"],"prefix":"10.2174","volume":"27","author":[{"given":"Liantao","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deguang","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengrong","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, No. 238 Jiefang Road, Wuhan,\nHubei 430060, People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/cncr.32802","volume":"126","author":"Henley S.J.","year":"2020","unstructured":"Henley S.J.; Ward E.M.; Scott S.; Ma J.; Anderson R.N.; Firth A.U.; Thomas C.C.; Islami F.; Weir H.K.; Lewis D.R.; Sherman R.L.; Wu M.; Benard V.B.; Richardson L.C.; Jemal A.; Cronin K.; Kohler B.A.; Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer  2020,126(10),2225-2249","journal-title":"Cancer"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"Siegel R.L.","year":"2021","unstructured":"Siegel R.L.; Miller K.D.; Fuchs H.E.; Jemal A.; Cancer Statistics, 2021. CA Cancer J Clin  2021,71(1),7-33","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nrclinonc.2015.123","volume":"12","author":"Arnedos M.","year":"2015","unstructured":"Arnedos M.; Vicier C.; Loi S.; Lefebvre C.; Michiels S.; Bonnefoi H.; Andre F.; Precision medicine for metastatic breast cancer-limitations and solutions. Nat Rev Clin Oncol  2015,12(12),693-704","journal-title":"Nat Rev Clin Oncol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Koboldt D.C.","year":"2012","unstructured":"Koboldt D.C.; Fulton R.S.; McLellan M.D.; Schmidt H.; Kalicki-Veizer J.; McMichael J.F.; Fulton L.L.; Dooling D.J.; Ding L.; Mardis E.R.; Wilson R.K.; Ally A.; Balasundaram M.; Butterfield Y.S.N.; Carlsen R.; Carter C.; Chu A.; Chuah E.; Chun H.J.E.; Coope R.J.N.; Dhalla N.; Guin R.; Hirst C.; Hirst M.; Holt R.A.; Lee D.; Li H.Y.I.; Mayo M.; Moore R.A.; Mungall A.J.; Pleasance E.; Robertson A.G.; Schein J.E.; Shafiei A.; Sipahimalani P.; Slobodan J.R.; Stoll D.; Tam A.; Thiessen N.; Varhol R.J.; Wye N.; Zeng T.; Zhao Y.J.; Birol I.; Jones S.J.M.; Marra M.A.; Cherniack A.D.; Saksena G.; Onofrio R.C.; Pho N.H.; Carter S.L.; Schumacher S.E.; Tabak B.; Hernandez B.; Gentry J.; Nguyen H.; Crenshaw A.; Ardlie K.; Beroukhim R.; Winckler W.; Getz G.; Gabriel S.B.; Meyerson M.; Chin L.; Park P.J.; Kucherlapati R.; Hoadley K.A.; Auman J.T.; Fan C.; Turman Y.J.; Shi Y.; Li L.; Topal M.D.; He X.P.; Chao H.H.; Prat A.; Silva G.O.; Iglesia M.D.; Zhao W.; Usary J.; Berg J.S.; Adams M.; Booker J.; Wu J.Y.; Gulabani A.; Bodenheimer T.; Hoyle A.P.; Simons J.V.; Soloway M.G.; Mose L.E.; Jefferys S.R.; Balu S.; Parker J.S.; Hayes D.N.; Perou C.M.; Malik S.; Mahurkar S.; Shen H.; Weisenberger D.J.; Triche T.; Lai P.H.; Bootwalla M.S.; Maglinte D.T.; Berman B.P.; Van den Berg D.J.; Baylin S.B.; Laird P.W.; Creighton C.J.; Donehower L.A.; Getz G.; Noble M.; Voet D.; Saksena G.; Gehlenborg N.; DiCara D.; Zhang J.H.; Zhang H.L.; Wu C.J.; Liu S.Y.; Lawrence M.S.; Zou L.H.; Sivachenko A.; Lin P.; Stojanov P.; Jing R.; Cho J.; Sinha R.; Park R.W.; Nazaire M.D.; Robinson J.; Thorvaldsdottir H.; Mesirov J.; Park P.J.; Chin L.; Reynolds S.; Kreisberg R.B.; Bernard B.; Bressler R.; Erkkila T.; Lin J.; Thorsson V.; Zhang W.; Shmulevich I.; Ciriello G.; Weinhold N.; Schultz N.; Gao J.J.; Cerami E.; Gross B.; Jacobsen A.; Sinha R.; Aksoy B.A.; Antipin Y.; Reva B.; Shen R.L.; Taylor B.S.; Ladanyi M.; Sander C.; Anur P.; Spellman P.T.; Lu Y.L.; Liu W.B.; Verhaak R.R.G.; Mills G.B.; Akbani R.; Zhang N.X.; Broom B.M.; Casasent T.D.; Wakefield C.; Unruh A.K.; Baggerly K.; Coombes K.; Weinstein J.N.; Haussler D.; Benz C.C.; Stuart J.M.; Benz S.C.; Zhu J.C.; Szeto C.C.; Scott G.K.; Yau C.; Paul E.O.; Carlin D.; Wong C.; Sokolov A.; Thusberg J.; Mooney S.; Ng S.; Goldstein T.C.; Ellrott K.; Grifford M.; Wilks C.; Ma S.; Craft B.; Yan C.H.; Hu Y.; Meerzaman D.; Gastier-Foster J.M.; Bowen J.; Ramirez N.C.; Black A.D.; Pyatt R.E.; White P.; Zmuda E.J.; Frick J.; Lichtenberg T.; Brookens R.; George M.M.; Gerken M.A.; Harper H.A.; Leraas K.M.; Wise L.J.; Tabler T.R.; McAllister C.; Barr T.; Hart-Kothari M.; Tarvin K.; Saller C.; Sandusky G.; Mitchell C.; Iacocca M.V.; Brown J.; Rabeno B.; Czerwinski C.; Petrelli N.; Dolzhansky O.; Abramov M.; Voronina O.; Potapova O.; Marks J.R.; Suchorska W.M.; Murawa D.; Kycler W.; Ibbs M.; Korski K.; Spychala A.; Murawa P.; Brzezinski J.J.; Perz H.; Lazniak R.; Teresiak M.; Tatka H.; Leporowska E.; Bogusz-Czerniewicz M.; Malicki J.; Mackiewicz A.; Wiznerowicz M.; Le X.V.; Kohl B.; Tien N.V.; Thorp R.; Bang N.V.; Sussman H.; Phu B.D.; Hajek R.; Hung N.P.; Tran V.T.P.; Thang H.Q.; Khan K.Z.; Penny R.; Mallery D.; Curley E.; Shelton C.; Yena P.; Ingle J.N.; Couch F.J.; Lingle W.L.; King T.A.; Gonzalez-Angulo A.M.; Mills G.B.; Dyer M.D.; Liu S.Y.; Meng X.L.; Patangan M.; Waldman F.; Stoppler H.; Rathmell W.K.; Thorne L.; Huang M.; Boice L.; Hill A.; Morrison C.; Gaudioso C.; Bshara W.; Daily K.; Egea S.C.; Pegram M.D.; Gomez-Fernandez C.; Dhir R.; Bhargava R.; Brufsky A.; Shriver C.D.; Hooke J.A.; Campbell J.L.; Mural R.J.; Hu H.; Somiari S.; Larson C.; Deyarmin B.; Kvecher L.; Kovatich A.J.; Ellis M.J.; King T.A.; Hu H.; Couch F.J.; Mural R.J.; Stricker T.; White K.; Olopade O.; Ingle J.N.; Luo C.Q.; Chen Y.Q.; Marks J.R.; Waldman F.; Wiznerowicz M.; Bose R.; Chang L.W.; Beck A.H.; Gonzalez-Angulo A.M.; Pihl T.; Jensen M.; Sfeir R.; Kahn A.; Chu A.; Kothiyal P.; Wang Z.N.; Snyder E.; Pontius J.; Ayala B.; Backus M.; Walton J.; Baboud J.; Berton D.; Nicholls M.; Srinivasan D.; Raman R.; Girshik S.; Kigonya P.; Alonso S.; Sanbhadti R.; Barletta S.; Pot D.; Sheth M.; Demchok J.A.; Shaw K.R.M.; Yang L.M.; Eley G.; Ferguson M.L.; Tarnuzzer R.W.; Zhang J.S.; Dillon L.A.L.; Buetow K.; Fielding P.; Ozenberger B.A.; Guyer M.S.; Sofia H.J.; Palchik J.D.; Canc Genome Atlas N.; Comprehensive molecular portraits of human breast tumours. Nature  2012,490(7418),61-70","journal-title":"Nature"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"Sung H.","year":"2021","unstructured":"Sung H.; Ferlay J.; Siegel R.L.; Laversanne M.; Soerjomataram I.; Jemal A.; Bray F.; Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2021,71(3),209-249","journal-title":"CA Cancer J Clin"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"Allemani C.","year":"2018","unstructured":"Allemani C.; Matsuda T.; Di Carlo V.; Harewood R.; Matz M.; Nik\u0161i\u0107, M.; Bonaventure, A.; Valkov, M.; Johnson, C.J.; Est&#xE8;ve, J.; Ogunbiyi, O.J.; Azevedo e Silva, G.; Chen, W.Q.; Eser, S.; Engholm, G.; Stiller, C.A.; Monnereau, A.; Woods, R.R.; Visser, O.; Lim, G.H.; Aitken, J.; Weir, H.K.; Coleman, M.P.; Bouzbid, S.; Hamdi-Ch&#xE9;rif, M.; Zaidi, Z.; Meguenni, K.; Regagba, D.; Bayo, S.; Cheick Bougadari, T.; Manraj, S.S.; Bendahhou, K.; Fabowale, A.; Bradshaw, D.; Somdyala, N.I.M.; Kumcher, I.; Moreno, F.; Calabrano, G.H.; Espinola, S.B.; Carballo Quintero, B.; Fita, R.; Diumenjo, M.C.; Laspada, W.D.; Iba&#xF1;ez, S.G.; Lima, C.A.; De Souza, P.C.F.; Del Pino, K.; Laporte, C.; Curado, M.P.; de Oliveira, J.C.; Veneziano, C.L.A.; Veneziano, D.B.; Latorre, M.R.D.O.; Tanaka, L.F.; Rebelo, M.S.; Santos, M.O.; Galaz, J.C.; Aparicio Aravena, M.; Sanhueza Monsalve, J.; Herrmann, D.A.; Vargas, S.; Herrera, V.M.; Uribe, C.J.; Bravo, L.E.; Garcia, L.S.; Arias-Ortiz, N.E.; Morantes, D.; Jurado, D.M.; Y&#xE9;pez Chamorro, M.C.; Delgado, S.; Ramirez, M.; Gal&#xE1;n Alvarez, Y.H.; Torres, P.; Mart&#xED;nez-Reyes, F.; Jaramillo, L.; Quinto, R.; Castillo, J.; Mendoza, M.; Cueva, P.; Y&#xE9;pez, J.G.; Bhakkan, B.; Deloumeaux, J.; Joachim, C.; Macni, J.; Carrillo, R.; Shalkow, K.J.; Rivera, G.R.; Poquioma, E.; Tortolero-Luna, G.; Zavala, D.; Alonso, R.; Barrios, E.; Eckstrand, A.; Nikiforuk, C.; Noonan, G.; Turner, D.; Kumar, E.; Zhang, B.; McCrate, F.R.; Ryan, S.; MacIntyre, M.; Saint-Jacques, N.; Nishri, D.E.; McClure, C.A.; Vriends, K.A.; Kozie, S.; Stuart-Panko, H.; Freeman, T.; George, J.T.; Brockhouse, J.T.; O\u2019Brien, D.K.; Holt, A.; Almon, L.; Kwong, S.; Morris, C.; Rycroft, R.; Mueller, L.; Phillips, C.E.; Brown, H.; Cromartie, B.; Schwartz, A.G.; Vigneau, F.; Levin, G.M.; Wohler, B.; Bayakly, R.; Ward, K.C.; Gomez, S.L.; McKinley, M.; Cress, R.; Green, M.D.; Miyagi, K.; Ruppert, L.P.; Lynch, C.F.; Huang, B.; Tucker, T.C.; Deapen, D.; Liu, L.; Hsieh, M.C.; Wu, X.C.; Schwenn, M.; Gershman, S.T.; Knowlton, R.C.; Alverson, G.; Copeland, G.E.; Bushhouse, S.; Rogers, D.B.; Jackson-Thompson, J.; Lemons, D.; Zimmerman, H.J.; Hood, M.; Roberts-Johnson, J.; Rees, J.R.; Riddle, B.; Pawlish, K.S.; Stroup, A.; Key, C.; Wiggins, C.; Kahn, A.R.; Schymura, M.J.; Radhakrishnan, S.; Rao, C.; Giljahn, L.K.; Slocumb, R.M.; Espinoza, R.E.; Khan, F.; Aird, K.G.; Beran, T.; Rubertone, J.J.; Slack, S.J.; Garcia, L.; Rousseau, D.L.; Janes, T.A.; Schwartz, S.M.; Bolick, S.W.; Hurley, D.M.; Whiteside, M.A.; Miller-Gianturco, P.; Williams, M.A.; Herget, K.; Sweeney, C.; Johnson, A.T.; Keitheri Cheteri, M.B.; Migliore Santiago, P.; Blankenship, S.E.; Farley, S.; Borchers, R.; Malicki, R.; Espinoza, J.R.; Grandpre, J.; Wilson, R.; Edwards, B.K.; Mariotto, A.; Lei, Y.; Wang, N.; Chen, J.S.; Zhou, Y.; He, Y.T.; Song, G.H.; Gu, X.P.; Mei, D.; Mu, H.J.; Ge, H.M.; Wu, T.H.; Li, Y.Y.; Zhao, D.L.; Jin, F.; Zhang, J.H.; Zhu, F.D.; Junhua, Q.; Yang, Y.L.; Jiang, C.X.; Biao, W.; Wang, J.; Li, Q.L.; Yi, H.; Zhou, X.; Dong, J.; Li, W.; Fu, F.X.; Liu, S.Z.; Chen, J.G.; Zhu, J.; Li, Y.H.; Lu, Y.Q.; Fan, M.; Huang, S.Q.; Guo, G.P.; Zhaolai, H.; Wei, K.; Zeng, H.; Demetriou, A.V.; Mang, W.K.; Ngan, K.C.; Kataki, A.C.; Krishnatreya, M.; Jayalekshmi, P.A.; Sebastian, P.; Nandakumar, A.; Malekzadeh, R.; Roshandel, G.; Keinan-Boker, L.; Silverman, B.G.; Ito, H.; Nakagawa, H.; Sato, M.; Tobori, F.; Nakata, I.; Teramoto, N.; Hattori, M.; Kaizaki, Y.; Moki, F.; Sugiyama, H.; Utada, M.; Nishimura, M.; Yoshida, K.; Kurosawa, K.; Nemoto, Y.; Narimatsu, H.; Sakaguchi, M.; Kanemura, S.; Naito, M.; Narisawa, R.; Miyashiro, I.; Nakata, K.; Sato, S.; Yoshii, M.; Oki, I.; Fukushima, N.; Shibata, A.; Iwasa, K.; Ono, C.; Nimri, O.; Jung, K.W.; Won, Y.J.; Alawadhi, E.; Elbasmi, A.; Ab Manan, A.; Adam, F.; Sanjaajmats, E.; Tudev, U.; Ochir, C.; Al Khater, A.M.; El Mistiri, M.M.; Teo, Y.Y.; Chiang, C.J.; Lee, W.C.; Buasom, R.; Sangrajrang, S.; Kamsa-ard, S.; Wiangnon, S.; Daoprasert, K.; Pongnikorn, D.; Leklob, A.; Sangkitipaiboon, S.; Geater, S.L.; Sriplung, H.; Ceylan, O.; K&#xF6;g, I.; Dirican, O.; K&#xF6;se, T.; Gurbuz, T.; Kara&#x15F;ahin, F.E.; Turhan, D.; Akta&#x15F; U.; Halat, Y.; Yakut, C.I.; Altinisik, M.; Cavusoglu, Y.; T&#xFC;rkk&#xF6;yl&#xFC;, A.; &#xDC;&#xE7;&#xFC;nc&#xFC;, N.; Hackl, M.; Zborovskaya, A.A.; Aleinikova, O.V.; Henau, K.; Van Eycken, L.; Valerianova, Z.; Yordanova, M.R.; \u0160ekerija, M.; Du\u0161ek, L.; Zvolsk&#xFD;, M.; Storm, H.; Innos, K.; M&#xE4;gi, M.; Malila, N.; Sepp&#xE4;, K.; J&#xE9;gu, J.; Velten, M.; Cornet, E.; Troussard, X.; Bouvier, A.M.; Guizard, A.V.; Bouvier, V.; Launoy, G.; Arveux, P.; Maynadi&#xE9;, M.; Mounier, M.; Woronoff, A.S.; Daoulas, M.; Robaszkiewicz, M.; Clavel, J.; Goujon, S.; Lacour, B.; Baldi, I.; Pouchieu, C.; Amadeo, B.; Coureau, G.; Orazio, S.; Preux, P.M.; Rharbaoui, F.; Marrer, E.; Tr&#xE9;tarre, B.; Colonna, M.; Delafosse, P.; Ligier, K.; Plouvier, S.; Cowppli-Bony, A.; Molini&#xE9;, F.; Bara, S.; Ganry, O.; Lap&#xF4;tre-Ledoux, B.; Grosclaude, P.; Bossard, N.; Uhry, Z.; Bray, F.; Pi&#xF1;eros, M.; Stabenow, R.; Wilsdorf-K&#xF6;hler, H.; Eberle, A.; Luttmann, S.; L&#xF6;hden, I.; Nennecke, A.L.; Kieschke, J.; Sirri, E.; Emrich, K.; Zeissig, S.R.; Holleczek, B.; Eisemann, N.; Katalinic, A.; Asquez, R.A.; Kumar, V.; Petridou, E.; &#xD3;lafsd&#xF3;ttir, E.J.; Tryggvad&#xF3;ttir, L.; Clough-Gorr, K.; Walsh, P.M.; Sundseth, H.; Mazzoleni, G.; Vittadello, F.; Coviello, E.; Cuccaro, F.; Galasso, R.; Sampietro, G.; Giacomin, A.; Magoni, M.; Ardizzone, A.; D\u2019Argenzio, A.; Castaing, M.; Grosso, G.; Lavecchia, A.M.; Sutera Sardo, A.; Gola, G.; Gatti, L.; Ricci, P.; Ferretti, S.; Serraino, D.; Zucchetto, A.; Celesia, M.V.; Filiberti, R.A.; Pannozzo, F.; Melcarne, A.; Quarta, F.; Russo, A.G.; Carrozzi, G.; Cirilli, C.; Cavalieri d\u2019Oro, L.; Rognoni, M.; Fusco, M.; Vitale, M.F.; Usala, M.; Cusimano, R.; Mazzucco, W.; Michiara, M.; Sgargi, P.; Boschetti, L.; Borciani, E.; Seghini, P.; Maule, M.M.; Merletti, F.; Tumino, R.; Mancuso, P.; Vicentini, M.; Cassetti, T.; Sassatelli, R.; Falcini, F.; Giorgetti, S.; Caiazzo, A.L.; Cavallo, R.; Cesaraccio, R.; Pirino, D.R.; Contrino, M.L.; Tisano, F.; Fanetti, A.C.; Maspero, S.; Carone, S.; Mincuzzi, A.; Candela, G.; Scuderi, T.; Gentilini, M.A.; Piffer, S.; Rosso, S.; Barchielli, A.; Caldarella, A.; Bianconi, F.; Stracci, F.; Contiero, P.; Tagliabue, G.; Rugge, M.; Zorzi, M.; Beggiato, S.; Brustolin, A.; Berrino, F.; Gatta, G.; Sant, M.; Buzzoni, C.; Mangone, L.; Capocaccia, R.; De Angelis, R.; Zanetti, R.; Maurina, A.; Pildava, S.; Lipunova, N.; Vincer&#x17E;evskien&#xE9;, I.; Agius, D.; Calleja, N.; Siesling, S.; Lar&#xF8;nningen, S.; M&#xF8;ller, B.; Dyzmann-Sroka, A.; Trojanowski, M.; G&#xF3;&#x17A;d&#x17A;, S.M\u0119&#x17C;yk, R.; Mierzwa, T.; Molong, L.; Rachtan, J.; Szewczyk, S.; BB\u0142aszczyk, J.; K\u0119pska, K.; Ko&#x15B;cia\u0144ska, B.; Taroci\u0144ska, K.; Zwierko, M.; Drosik, K.; Maksimowicz, K.M.; Purwin-Porowska, E.; Reca, E.; W&#xF3;jcik-Tomaszewska, J.; Tukiendorf, A.; Gr\u0105dalska-Lampart, M.; Radziszewska, A.U.; Gos, A.; Talerczyk, M.; Wyborska, M.; Didkowska, J.A.; Wojciechowska, U.; Bielska-Lasota, M.; Forjaz de Lacerda, G.; Rego, R.A.; Bastos, J.; Silva, M.A.; Antunes, L.; Laranja Pontes, J.; Mayer-da-Silva, A.; Miranda, A.; Blaga, L.M.; Coza, D.; Gusenkova, L.; Lazarevich, O.; Prudnikova, O.; Vjushkov, D.M.; Egorova, A.G.; Orlov, A.E.; Kudyakov, L.A.; Pikalova, L.V.; Adamcik, J.; Safaei Diba, C.; Primic-&#x17D;akelj, M.; Zadnik, V.; Larra&#xF1;aga, N.; Lopez de Munain, A.; Herrera, A.A.; Redondas, R.; Marcos-Gragera, R.; Vilardell Gil, M.L.; Molina, E.; S&#xE1;nchez Perez, M.J.; Franch Sureda, P.; Ramos Montserrat, M.; Chirlaque, M.D.; Navarro, C.; Ardanaz, E.E.; Guevara, M.M.; Fern&#xE1;ndez-Delgado, R.; Peris-Bonet, R.; Carulla, M.; Galceran, J.; Alberich, C.; Vicente-Raneda, M.; Khan, S.; Pettersson, D.; Dickman, P.; Avelina, I.; Staehelin, K.; Camey, B.; Bouchardy, C.; Schaffar, R.; Frick, H.; Herrmann, C.; Bulliard, J.L.; Maspoli-Conconi, M.; Kuehni, C.E.; Redmond, S.M.; Bordoni, A.; Ortelli, L.; Chiolero, A.; Konzelmann, I.; Matthes, K.L.; Rohrmann, S.; Broggio, J.; Rashbass, J.; Fitzpatrick, D.; Gavin, A.; Clark, D.I.; Deas, A.J.; Huws, D.W.; White, C.; Montel, L.; Rachet, B.; Turculet, A.D.; Stephens, R.; Chalker, E.; Phung, H.; Walton, R.; You, H.; Guthridge, S.; Johnson, F.; Gordon, P.; D\u2019Onise, K.; Priest, K.; Stokes, B.C.; Venn, A.; Farrugia, H.; Thursfield, V.; Dowling, J.; Currow, D.; Hendrix, J.; Lewis, C. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet  2018,391(10125),1023-1075","journal-title":"Lancet"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1530\/ERC-17-0309","volume":"25","author":"Tulotta C.","year":"2018","unstructured":"Tulotta C.; Ottewell P.; The role of IL-1B in breast cancer bone metastasis. Endocr Relat Cancer  2018,25(7),R421-R434","journal-title":"Endocr Relat Cancer"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","volume":"35","author":"Chaffer C.L.","year":"2016","unstructured":"Chaffer C.L.; San Juan B.P.; Lim E.; Weinberg R.A.; EMT, cell plasticity and metastasis. Cancer Metastasis Rev  2016,35(4),645-654","journal-title":"Cancer Metastasis Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.08.003","volume":"62","author":"Karamanou K.","year":"2020","unstructured":"Karamanou K.; Franchi M.; Vynios D.; Br&#xE9;zillon S.; Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin Cancer Biol  2020,62,125-133","journal-title":"Semin Cancer Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"Kalluri R.","year":"2009","unstructured":"Kalluri R.; Weinberg R.A.; The basics of epithelial-mesenchymal transition. J Clin Invest  2009,119(6),1420-1428","journal-title":"J Clin Invest"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41388-020-01539-x","volume":"40","author":"Kong D.","year":"2021","unstructured":"Kong D.; Zhou H.; Neelakantan D.; Hughes C.J.; Hsu J.Y.; Srinivasan R.R.; Lewis M.T.; Ford H.L.; VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene  2021,40(5),964-979","journal-title":"Oncogene"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"Gupta G.P.","year":"2006","unstructured":"Gupta G.P.; Massagu&#xE9;, J. Cancer metastasis: Building a framework. Cell  2006,127(4),679-695","journal-title":"Cell"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/onc.2013.187","volume":"33","author":"Davis F.M.","year":"2014","unstructured":"Davis F.M.; Azimi I.; Faville R.A.; Peters A.A.; Jalink K.; Putney J.W.; Goodhill G.J.; Thompson E.W.; Roberts-Thomson S.J.; Monteith G.R.; Induction of epithelial\u2013mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene  2014,33(18),2307-2316","journal-title":"Oncogene"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"Zeng K.","year":"2018","unstructured":"Zeng K.; He B.; Yang B.B.; Xu T.; Chen X.; Xu M.; Liu X.; Sun H.; Pan Y.; Wang S.; The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer  2018,17(1),160","journal-title":"Mol Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctrv.2018.08.004","volume":"70","author":"Samuel S.M.","year":"2018","unstructured":"Samuel S.M.; Varghese E.; Varghese S.; B&#xFC;sselberg D.; Challenges and perspectives in the treatment of diabetes associated breast cancer. Cancer Treat Rev  2018,70,98-111","journal-title":"Cancer Treat Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.joca.2014.11.002","volume":"23","author":"Sin A.","year":"2015","unstructured":"Sin A.; Tang W.; Wen C.Y.; Chung S.K.; Chiu K.Y.; The emerging role of endothelin-1 in the pathogenesis of subchondral bone disturbance and osteoarthritis. Osteoarthr Cartil  2015,23(4),516-524","journal-title":"Osteoarthr Cartil"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.joca.2020.12.009","volume":"29","author":"Astephen Wilson J.L.","year":"2021","unstructured":"Astephen Wilson J.L.; Kobsar D.; Osteoarthritis year in review 2020: Mechanics. Osteoarthr Cartil  2021,29(2),161-169","journal-title":"Osteoarthr Cartil"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.joca.2020.12.006","volume":"29","author":"Jacob L.","year":"2021","unstructured":"Jacob L.; Kostev K.; Osteoarthritis and the incidence of fracture in the United Kingdom: A retrospective cohort study of 258,696 patients. Osteoarthr Cartil  2021,29(2),215-221","journal-title":"Osteoarthr Cartil"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"Glyn-Jones S.","year":"2015","unstructured":"Glyn-Jones S.; Palmer A.J.R.; Agricola R.; Price A.J.; Vincent T.L.; Weinans H.; Carr A.J.;  Osteoarthritis Lancet  2015,386(9991),376-387","journal-title":"Osteoarthritis Lancet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10911-015-9349-9","volume":"21","author":"Sharma T.","year":"2016","unstructured":"Sharma T.; Radosevich J.A.; Pachori G.; Mandal C.C.; A molecular view of pathological microcalcification in breast cancer. J Mammary Gland Biol Neoplasia  2016,21(1-2),25-40","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e1356142","DOI":"10.1080\/2162402X.2017.1356142","volume":"6","author":"Quigley D.A.","year":"2017","unstructured":"Quigley D.A.; Tahiri A.; L&#xFC;ders T.; Riis M.H.; Balmain A.; B&#xF8;rresen-Dale A.L.; Bukholm I.; Kristensen V.; Age, estrogen, and immune response in breast adenocarcinoma and adjacent normal tissue. OncoImmunology  2017,6(11),e1356142","journal-title":"OncoImmunology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"8613","DOI":"10.3390\/ijms21228613","volume":"21","author":"Clemenceau A.","year":"2020","unstructured":"Clemenceau A.; Michou L.; Diorio C.; Durocher F.; Breast cancer and microcalcifications: An osteoimmunological disorder? Int J Mol Sci  2020,21(22),8613","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ejca.2010.11.023","volume":"47","author":"Wagner P.","year":"2011","unstructured":"Wagner P.; Olsson H.; Lidgren L.; Robertsson O.; Ranstam J.; Increased cancer risks among arthroplasty patients: 30year follow-up of the Swedish knee arthroplasty register. Eur J Cancer  2011,47(7),1061-1071","journal-title":"Eur J Cancer"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1093\/rheumatology\/keaa166","volume":"59","author":"Ward M.M.","year":"2020","unstructured":"Ward M.M.; Alehashemi S.; Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis. Rheumatology  2020,59(12),3817-3825","journal-title":"Rheumatology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10911-018-9396-0","volume":"23","author":"Bonfiglio R.","year":"2018","unstructured":"Bonfiglio R.; Scimeca M.; Toschi N.; Pistolese C.A.; Giannini E.; Antonacci C.; Ciuffa S.; Tancredi V.; Tarantino U.; Albonici L.; Bonanno E.; Radiological, histological and chemical analysis of breast microcalcifications: Diagnostic value and biological significance. J Mammary Gland Biol Neoplasia  2018,23(1-2),89-99","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1470-2045(18)30862-3","volume":"20","author":"Gnant M.","year":"2019","unstructured":"Gnant M.; Pfeiler G.; Steger G.G.; Egle D.; Greil R.; Fitzal F.; Wette V.; Balic M.; Haslbauer F.; Melbinger-Zeinitzer E.; Bjelic-Radisic V.; Jakesz R.; Marth C.; Sevelda P.; Mlineritsch B.; Exner R.; Fesl C.; Frantal S.; Singer C.F.; Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol  2019,20(3),339-351","journal-title":"Lancet Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13058-018-1067-y","volume":"20","author":"Vetter M.","year":"2018","unstructured":"Vetter M.; Landin J.; Szczerba B.M.; Castro-Giner F.; Gkountela S.; Donato C.; Krol I.; Scherrer R.; Balmelli C.; Malinovska A.; Zippelius A.; Kurzeder C.; Heinzelmann-Schwarz V.; Weber W.P.; Rochlitz C.; Aceto N.; Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer. Breast Cancer Res  2018,20(1),141","journal-title":"Breast Cancer Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"75571","DOI":"10.18632\/oncotarget.12289","volume":"7","author":"Holen I.","year":"2016","unstructured":"Holen I.; Lefley D.V.; Francis S.E.; Rennicks S.; Bradbury S.; Coleman R.E.; Ottewell P.; IL-1 drives breast cancer growth and bone metastasis in vivo. Oncotarget  2016,7(46),75571-75584","journal-title":"Oncotarget"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1158\/0008-5472.CAN-18-0413","volume":"78","author":"Wu T.C.","year":"2018","unstructured":"Wu T.C.; Xu K.; Martinek J.; Young R.R.; Banchereau R.; George J.; Turner J.; Kim K.I.; Zurawski S.; Wang X.; Blankenship D.; Brookes H.M.; Marches F.; Obermoser G.; Lavecchio E.; Levin M.K.; Bae S.; Chung C.H.; Smith J.L.; Cepika A.M.; Oxley K.L.; Snipes G.J.; Banchereau J.; Pascual V.; O\u2019Shaughnessy J.; Palucka A.K.; IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer. Cancer Res  2018,78(18),5243-5258","journal-title":"Cancer Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-18-2202","volume":"25","author":"Tulotta C.","year":"2019","unstructured":"Tulotta C.; Lefley D.V.; Freeman K.; Gregory W.M.; Hanby A.M.; Heath P.R.; Nutter F.; Wilkinson J.M.; Spicer-Hadlington A.R.; Liu X.; Bradbury S.M.J.; Hambley L.; Cookson V.; Allocca G.; Kruithof de Julio M.; Coleman R.E.; Brown J.E.; Holen I.; Ottewell P.D.; Endogenous production of IL1B by breast cancer cells drives metastasis and colonization of the bone microenvironment. Clin Cancer Res  2019,25(9),2769-2782","journal-title":"Clin Cancer Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1101\/gad.262642.115","volume":"29","author":"Rodriguez-Barrueco R.","year":"2015","unstructured":"Rodriguez-Barrueco R.; Yu J.; Saucedo-Cuevas L.P.; Olivan M.; Llobet-Navas D.; Putcha P.; Castro V.; Murga-Penas E.M.; Collazo-Lorduy A.; Castillo-Martin M.; Alvarez M.; Cordon-Cardo C.; Kalinsky K.; Maurer M.; Califano A.; Silva J.M.; Inhibition of the autocrine IL-6\u2013JAK2\u2013STAT3\u2013calprotectin axis as targeted therapy for HR \u2212 \/HER2 + breast cancers. Genes Dev  2015,29(15),1631-1648","journal-title":"Genes Dev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/mc.23234","volume":"59","author":"Alraouji N.N.","year":"2020","unstructured":"Alraouji N.N.; Al-Mohanna F.H.; Ghebeh H.; Arafah M.; Almeer R.; Al-Tweigeri T.; Aboussekhra A.; Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triplenegative breast cancer. Mol Carcinog  2020,59(9),1041-1051","journal-title":"Mol Carcinog"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-018-0981-3","volume":"20","author":"Jin K.","year":"2018","unstructured":"Jin K.; Pandey N.B.; Popel A.S.; Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis. Breast Cancer Res  2018,20(1),54","journal-title":"Breast Cancer Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/brv.12595","volume":"95","author":"Yan J.","year":"2020","unstructured":"Yan J.; Qin W.; Xiao B.; Wan Q.; Tay F.R.; Niu L.; Jiao K.; Pathological calcification in osteoarthritis: An outcome or a disease initiator? Biol Rev Camb Philos Soc  2020,95(4),960-985","journal-title":"Biol Rev Camb Philos Soc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.3390\/ijms20225633","volume":"20","author":"Scimeca M.","year":"2019","unstructured":"Scimeca M.; Bonfiglio R.; Menichini E.; Albonici L.; Urbano N.; De Caro M.T.; Mauriello A.; Schillaci O.; Gambacurta A.; Bonanno E.; Microcalcifications drive breast cancer occurrence and development by macrophage-mediated epithelial to mesenchymal transition. Int J Mol Sci  2019,20(22),5633","journal-title":"Int J Mol Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S460","DOI":"10.21037\/tlcr.2019.12.20","volume":"8","author":"Hsiao Y.W.","year":"2019","unstructured":"Hsiao Y.W.; Lu T.P.; Text-mining in cancer research may help identify effective treatments. Transl Lung Cancer Res  2019,8(S4),S460-S463","journal-title":"Transl Lung Cancer Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4939-9089-4_13","volume":"1939","author":"Zheng S.","year":"2019","unstructured":"Zheng S.; Dharssi S.; Wu M.; Li J.; Lu Z.; Text mining for drug discovery. Methods Mol Biol  2019,1939,231-252","journal-title":"Methods Mol Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/d41586-019-01978-x","volume":"571","author":"Isayev O.","year":"2019","unstructured":"Isayev O.; Text mining facilitates materials discovery. Nature  2019,571(7763),42-43","journal-title":"Nature"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/1541-4337.12540","volume":"19","author":"Tao D.","year":"2020","unstructured":"Tao D.; Yang P.; Feng H.; Utilization of text mining as a big data analysis tool for food science and nutrition. Compr Rev Food Sci Food Saf  2020,19(2),875-894","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/bib\/bbaa296","volume":"22","author":"Wang L.L.","year":"2021","unstructured":"Wang L.L.; Lo K.; Text mining approaches for dealing with the rapidly expanding literature on COVID-19. Brief Bioinform  2021,22(2),781-799","journal-title":"Brief Bioinform"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/bioinformatics\/btz682","volume":"36","author":"Lee J.","year":"2020","unstructured":"Lee J.; Yoon W.; Kim S.; Kim D.; Kim S.; So C.H.; Kang J.; BioBERT: A pre-trained biomedical language representation model for biomedical text mining. Bioinformatics  2020,36(4),1234-1240","journal-title":"Bioinformatics"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"btz807","DOI":"10.1093\/bioinformatics\/btz807","volume":"36","author":"Wang J.H.","year":"2019","unstructured":"Wang J.H.; Zhao L.F.; Wang H.F.; Wen Y.T.; Jiang K.K.; Mao X.M.; Zhou Z.Y.; Yao K.T.; Geng Q.S.; Guo D.; Huang Z.X.; GenCLiP 3: Mining human genes\u2019 functions and regulatory networks from PubMed based on co-occurrences and natural language processing. Bioinformatics  2019,36(6),btz807","journal-title":"Bioinformatics"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/btu241","volume":"30","author":"Wang J.H.","year":"2014","unstructured":"Wang J.H.; Zhao L.F.; Lin P.; Su X.R.; Chen S.J.; Huang L.Q.; Wang H.F.; Zhang H.; Hu Z.F.; Yao K.T.; Huang Z.X.; GenCLiP 2.0: A web server for functional clustering of genes and construction of molecular networks based on free terms. Bioinformatics  2014,30(17),2534-2536","journal-title":"Bioinformatics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.clinthera.2019.04.003","volume":"41","author":"Zhang N.","year":"2019","unstructured":"Zhang N.; Xu W.; Wang S.; Qiao Y.; Zhang X.; Computational drug discovery in chemotherapy-induced alopecia via text mining and biomedical databases. Clin Ther  2019,41(5),972-980.e8","journal-title":"Clin Ther"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00520-018-4096-2","volume":"26","author":"Kirk J.","year":"2018","unstructured":"Kirk J.; Shah N.; Noll B.; Stevens C.B.; Lawler M.; Mougeot F.B.; Mougeot J.L.C.; Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy. Support Care Cancer  2018,26(8),2695-2705","journal-title":"Support Care Cancer"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.7150\/ijms.52846","volume":"18","author":"Hu D.","year":"2021","unstructured":"Hu D.; Jiang J.; Lin Z.; Zhang C.; Moonasar N.; Qian S.; Identification of key genes and pathways in scleral extracellular matrix remodeling in glaucoma: Potential therapeutic agents discovered using bioinformatics analysis. Int J Med Sci  2021,18(7),1554-1565","journal-title":"Int J Med Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"Szklarczyk D.","year":"2021","unstructured":"Szklarczyk D.; Gable A.L.; Nastou K.C.; Lyon D.; Kirsch R.; Pyysalo S.; Doncheva N.T.; Legeay M.; Fang T.; Bork P.; Jensen L.J.; von Mering C.; The STRING database in 2021: Customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res  2021,49(D1),D605-D612","journal-title":"Nucleic Acids Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.omtn.2020.06.001","volume":"21","author":"Yi L.","year":"2020","unstructured":"Yi L.; Wu G.; Guo L.; Zou X.; Huang P.; Comprehensive analysis of the PD-L1 and immune infiltrates of m6A RNA methylation regulators in head and neck squamous cell carcinoma. Mol Ther Nucleic Acids  2020,21,299-314","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e1629261","DOI":"10.1080\/2162402X.2019.1629261","volume":"8","author":"Koh Y.W.","year":"2019","unstructured":"Koh Y.W.; Han J.H.; Haam S.; Jung J.; Lee H.W.; Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients. OncoImmunol  2019,8(10),e1629261","journal-title":"OncoImmunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"Hoadley K.A.","year":"2014","unstructured":"Hoadley K.A.; Yau C.; Wolf D.M.; Cherniack A.D.; Tamborero D.; Ng S.; Leiserson M.D.M.; Niu B.; McLellan M.D.; Uzunangelov V.; Zhang J.; Kandoth C.; Akbani R.; Shen H.; Omberg L.; Chu A.; Margolin A.A.; van\u2019t Veer L.J.; Lopez-Bigas N.; Laird P.W.; Raphael B.J.; Ding L.; Robertson A.G.; Byers L.A.; Mills G.B.; Weinstein J.N.; Van Waes C.; Chen Z.; Collisson E.A.; Benz C.C.; Perou C.M.; Stuart J.M.; Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell  2014,158(4),929-944","journal-title":"Cell"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"djw144","DOI":"10.1093\/jnci\/djw144","volume":"108","author":"Iglesia M.D.","year":"2016","unstructured":"Iglesia M.D.; Parker J.S.; Hoadley K.A.; Serody J.S.; Perou C.M.; Vincent B.G.; Genomic analysis of immune cell infiltrates across 11 tumor types. J Natl Cancer Inst  2016,108(11),djw144","journal-title":"J Natl Cancer Inst"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Zhou Y.","year":"2019","unstructured":"Zhou Y.; Zhou B.; Pache L.; Chang M.; Khodabakhshi A.H.; Tanaseichuk O.; Benner C.; Chanda S.K.; Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun  2019,10(1),1523","journal-title":"Nat Commun"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Tang Z.","year":"2017","unstructured":"Tang Z.; Li C.; Kang B.; Gao G.; Li C.; Zhang Z.; GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res  2017,45(W1),W98-W102","journal-title":"Nucleic Acids Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Tang Z.","year":"2019","unstructured":"Tang Z.; Kang B.; Li C.; Chen T.; Zhang Z.; GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res  2019,47(W1),W556-W560","journal-title":"Nucleic Acids Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"Li C.","year":"2021","unstructured":"Li C.; Tang Z.; Zhang W.; Ye Z.; Liu F.; GEPIA2021: Integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res  2021,49(W1),W242-W246","journal-title":"Nucleic Acids Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"D1068","DOI":"10.1093\/nar\/gkx1143","volume":"46","author":"Cotto K.C.","year":"2018","unstructured":"Cotto K.C.; Wagner A.H.; Feng Y.Y.; Kiwala S.; Coffman A.C.; Spies G.; Wollam A.; Spies N.C.; Griffith O.L.; Griffith M.; DGIdb 3.0: A redesign and expansion of the drug\u2013gene interaction database. Nucleic Acids Res  2018,46(D1),D1068-D1073","journal-title":"Nucleic Acids Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"Wishart D.S.","year":"2018","unstructured":"Wishart D.S.; Feunang Y.D.; Guo A.C.; Lo E.J.; Marcu A.; Grant J.R.; Sajed T.; Johnson D.; Li C.; Sayeeda Z.; Assempour N.; Iynkkaran I.; Liu Y.; Maciejewski A.; Gale N.; Wilson A.; Chin L.; Cummings R.; Le D.; Pon A.; Knox C.; Wilson M.; DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res  2018,46(D1),D1074-D1082","journal-title":"Nucleic Acids Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.semarthrit.2013.11.012","volume":"43","author":"Nelson A.E.","year":"2014","unstructured":"Nelson A.E.; Allen K.D.; Golightly Y.M.; Goode A.P.; Jordan J.M.; A systematic review of recommendations and guidelines for the management of osteoarthritis: The Chronic Osteoarthritis Management Initiative of the U.S. Bone and Joint Initiative. Semin Arthritis Rheum  2014,43(6),701-712","journal-title":"Semin Arthritis Rheum"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrrheum.2014.61","volume":"10","author":"Block J.A.","year":"2014","unstructured":"Block J.A.; OA guidelines: Improving care or merely codifying practice? Nat Rev Rheumatol  2014,10(6),324-326","journal-title":"Nat Rev Rheumatol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"Hunter D.J.","year":"2019","unstructured":"Hunter D.J.; Bierma-Zeinstra S.;  Osteoarthritis Lancet  2019,393(10182),1745-1759","journal-title":"Osteoarthritis Lancet"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/S0140-6736(18)31777-X","volume":"392","author":"Ferguson R.J.","year":"2018","unstructured":"Ferguson R.J.; Palmer A.J.R.; Taylor A.; Porter M.L.; Malchau H.; Glyn-Jones S.; Hip replacement. Lancet  2018,392(10158),1662-1671","journal-title":"Lancet"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(11)60752-6","volume":"379","author":"Carr A.J.","year":"2012","unstructured":"Carr A.J.; Robertsson O.; Graves S.; Price A.J.; Arden N.K.; Judge A.; Beard D.J.; Knee replacement. Lancet  2012,379(9823),1331-1340","journal-title":"Lancet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e000922","DOI":"10.1136\/bmjsem-2020-000922","volume":"6","author":"Smith-Turchyn J.","year":"2020","unstructured":"Smith-Turchyn J.; Mukherjee S.; Richardson J.; Ball E.; Bordeleau L.; Neil-Sztramko S.; Levine O.; Thabane L.; Sathiyapalan A.; Sabiston C.; Evaluation of a novel strategy to implement exercise evidence into clinical practice in breast cancer care: protocol for the NEXT-BRCA randomised controlled trial. BMJ Open Sport Exerc Med  2020,6(1),e000922","journal-title":"BMJ Open Sport Exerc Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"CD005001","DOI":"10.1002\/14651858.CD005001.pub3","volume":"2016","author":"Furmaniak A.C.","year":"2016","unstructured":"Furmaniak A.C.; Menig M.; Markes M.H.; Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Libr  2016,2016(9),CD005001","journal-title":"Cochrane Libr"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"j1131","DOI":"10.1136\/bmj.j1131","volume":"356","author":"Ferket B.S.","year":"2017","unstructured":"Ferket B.S.; Feldman Z.; Zhou J.; Oei E.H.; Bierma-Zeinstra S.M.A.; Mazumdar M.; Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative. BMJ  2017,356,j1131","journal-title":"BMJ"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/13697130701857639","volume":"11","author":"Tank&#xF3; L.B.","year":"2008","unstructured":"Tank&#xF3; L.B.; S&#xF8;ndergaard B.C.; Oestergaard S.; Karsdal M.A.; Christiansen C.; An update review of cellular mechanisms conferring the indirect and direct effects of estrogen on articular cartilage. Climacteric  2008,11(1),4-16","journal-title":"Climacteric"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(15)61074-1","volume":"386","year":"2015","unstructured":"Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials. Lancet Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) 2015,386(10001),1341-1352","journal-title":"Lancet"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jnci\/djx141","volume":"110","author":"Goldvaser H.","year":"2018","unstructured":"Goldvaser H.; Barnes T.A.; \u0160eruga B.; Cescon D.W.; Oca&#xF1;a A.; Ribnikar D.; Amir E.; Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: A systematic review and meta-analysis. J Natl Cancer Inst  2018,110(1),31-39","journal-title":"J Natl Cancer Inst"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","volume":"25","author":"Coleman R.","year":"2014","unstructured":"Coleman R.; Body J.J.; Aapro M.; Hadji P.; Herrstedt J.; Bone health in cancer patients. ESMO Clinical Practice Guidelines Ann Oncol  2014,25(S3),iii124-iii137","journal-title":"ESMO Clinical Practice Guidelines Ann Oncol"},{"key":"ref=70","first-page":"101","author":"Shapiro C.L.","year":"1994","unstructured":"Shapiro C.L.; Recht A.; Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr  [PMID: 79994521994(16),101-112","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10549-007-9774-6","volume":"111","author":"Henry N.L.","year":"2008","unstructured":"Henry N.L.; Giles J.T.; Ang D.; Mohan M.; Dadabhoy D.; Robarge J.; Hayden J.; Lemler S.; Shahverdi K.; Powers P.; Li L.; Flockhart D.; Stearns V.; Hayes D.F.; Storniolo A.M.; Clauw D.J.; Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat  2008,111(2),365-372","journal-title":"Breast Cancer Res Treat"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/cncr.24419","volume":"115","author":"Mao J.J.","year":"2009","unstructured":"Mao J.J.; Stricker C.; Bruner D.; Xie S.; Bowman M.A.; Farrar J.T.; Greene B.T.; DeMichele A.; Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer  2009,115(16),3631-3639","journal-title":"Cancer"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/dvdy.24563","volume":"246","author":"Milstone Z.J.","year":"2017","unstructured":"Milstone Z.J.; Lawson G.; Trivedi C.M.; Histone deacetylase 1 and 2 are essential for murine neural crest proliferation, pharyngeal arch development, and craniofacial morphogenesis. Dev Dyn  2017,246(12),1015-1026","journal-title":"Dev Dyn"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.tips.2009.09.007","volume":"30","author":"Kr&#xE4;mer O.H.","year":"2009","unstructured":"Kr&#xE4;mer O.H.; HDAC2: A critical factor in health and disease. Trends Pharmacol Sci  2009,30(12),647-655","journal-title":"Trends Pharmacol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"pe1","DOI":"10.1126\/scisignal.3103pe1","volume":"3","author":"Riccio A.","year":"2010","unstructured":"Riccio A.; New endogenous regulators of class I histone deacetylases. Sci Signal  2010,3(103),pe1","journal-title":"Sci Signal"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1158\/0008-5472.CAN-13-3531","volume":"74","author":"Lee Y.H.","year":"2014","unstructured":"Lee Y.H.; Seo D.; Choi K.J.; Andersen J.B.; Won M.A.; Kitade M.; G&#xF3;mez-Quiroz L.E.; Judge A.D.; Marquardt J.U.; Raggi C.; Conner E.A.; MacLachlan I.; Factor V.M.; Thorgeirsson S.S.; Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2. Cancer Res  2014,74(17),4752-4761","journal-title":"Cancer Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00204-018-2229-5","volume":"92","author":"Kiweler N.","year":"2018","unstructured":"Kiweler N.; Brill B.; Wirth M.; Breuksch I.; Laguna T.; Dietrich C.; Strand S.; Schneider G.; Groner B.; Butter F.; Heinzel T.; Brenner W.; Kr&#xE4;mer O.H.; The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cells. Arch Toxicol  2018,92(7),2227-2243","journal-title":"Arch Toxicol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2017.00902","volume":"8","author":"Huang W.T.","year":"2017","unstructured":"Huang W.T.; Tsai Y.H.; Chen S.H.; Kuo C.W.; Kuo Y.L.; Lee K.T.; Chen W.C.; Wu P.C.; Chuang C.Y.; Cheng S.M.; Lin C.H.; Leung E.Y.; Chang Y.C.; Cheung C.H.A.; HDAC2 and HDAC5 up-regulations modulate survivin and miR-125a-5p expressions and promote hormone therapy resistance in estrogen receptor positive breast cancer cells. Front Pharmacol  2017,8,902","journal-title":"Front Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.mcp.2020.101649","volume":"53","author":"Darvishi N.","year":"2020","unstructured":"Darvishi N.; Rahimi K.; Mansouri K.; Fathi F.; Menbari M.N.; Mohammadi G.; Abdi M.; MiR-646 prevents proliferation and progression of human breast cancer cell lines by suppressing HDAC2 expression. Mol Cell Probes  2020,53,101649","journal-title":"Mol Cell Probes"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"9172","DOI":"10.1002\/jcb.28193","volume":"120","author":"Bayat S.","year":"2019","unstructured":"Bayat S.; Mansoori D.S.; Mansoori D.N.; Shekari K.M.; Alivand M.R.; Downregulation of HDAC2 and HDAC3via oleuropein as a potent prevention and therapeutic agent in MCF-7 breast cancer cells. J Cell Biochem  2019,120(6),9172-9180","journal-title":"J Cell Biochem"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","volume":"26","author":"Zhang N.","year":"2019","unstructured":"Zhang N.; Zhang H.; Liu Y.; Su P.; Zhang J.; Wang X.; Sun M.; Chen B.; Zhao W.; Wang L.; Wang H.; Moran M.S.; Haffty B.G.; Yang Q.; SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1\/2. Cell Death Differ  2019,26(5),843-859","journal-title":"Cell Death Differ"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.7150\/thno.41008","volume":"10","author":"Zhang Z.","year":"2020","unstructured":"Zhang Z.; Qiu N.; Yin J.; Zhang J.; Liu H.; Guo W.; Liu M.; Liu T.; Chen D.; Luo K.; Li H.; He Z.; Liu J.; Zheng G.; SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression. Theranostics  2020,10(10),4290-4307","journal-title":"Theranostics"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1038\/onc.2013.332","volume":"33","author":"Roy S.S.","year":"2014","unstructured":"Roy S.S.; Gonugunta V.K.; Bandyopadhyay A.; Rao M.K.; Goodall G.J.; Sun L-Z.; Tekmal R.R.; Vadlamudi R.K.; Significance of PELP1\/HDAC2\/miR-200 regulatory network in EMT and metastasis of breast cancer. Oncogene  2014,33(28),3707-3716","journal-title":"Oncogene"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/cr.2010.118","volume":"21","author":"Fu J.","year":"2011","unstructured":"Fu J.; Qin L.; He T.; Qin J.; Hong J.; Wong J.; Liao L.; Xu J.; The TWIST\/Mi2\/NuRD protein complex and its essential role in cancer metastasis. Cell Res  2011,21(2),275-289","journal-title":"Cell Res"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13075-020-02373-y","volume":"23","author":"Wang Z.","year":"2021","unstructured":"Wang Z.; Zhou N.; Wang W.; Yu Y.; Xia L.; Li N.; HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis. Arthritis Res Ther  2021,23(1),78","journal-title":"Arthritis Res Ther"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.joca.2016.11.006","volume":"25","author":"Mao G.","year":"2017","unstructured":"Mao G.; Zhang Z.; Huang Z.; Chen W.; Huang G.; Meng F.; Zhang Z.; Kang Y.; MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation. Osteoarthr Cartil  2017,25(4),521-532","journal-title":"Osteoarthr Cartil"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1002\/art.37965","volume":"65","author":"Culley K.L.","year":"2013","unstructured":"Culley K.L.; Hui W.; Barter M.J.; Davidson R.K.; Swingler T.E.; Destrument A.P.M.; Scott J.L.; Donell S.T.; Fenwick S.; Rowan A.D.; Young D.A.; Clark I.M.; Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum  2013,65(7),1822-1830","journal-title":"Arthritis Rheum"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/path.860","volume":"194","author":"van Tilborg A.A.G.","year":"2001","unstructured":"van Tilborg A.A.G.; de Vries A.; Zwarthoff E.C.; The chromosome 9q genesTGFBR1,TSC1, andZNF189 are rarely mutated in bladder cancer. J Pathol  2001,194(1),76-80","journal-title":"J Pathol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1158\/1055-9965.EPI-06-0965","volume":"16","author":"Daley D.","year":"2007","unstructured":"Daley D.; Morgan W.; Lewis S.; Willis J.; Elston R.C.; Markowitz S.D.; Wiesner G.L.; Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia? Cancer Epidemiol Biomarkers Prev  2007,16(5),892-894","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/sj.onc.1209092","volume":"25","author":"Bose S.","year":"2006","unstructured":"Bose S.; Morgan L.J.; Booth D.R.; Goudie D.R.; Ferguson-Smith M.A.; Richards F.M.; The elusive multiple self-healing squamous epithelioma (MSSE) gene: Further mapping, analysis of candidates, and loss of heterozygosity. Oncogene  2006,25(5),806-812","journal-title":"Oncogene"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nrc1208","volume":"3","author":"Siegel P.M.","year":"2003","unstructured":"Siegel P.M.; Massagu&#xE9; J.; Cytostatic and apoptotic actions of TGF-&#x3B2; in homeostasis and cancer. Nat Rev Cancer  2003,3(11),807-820","journal-title":"Nat Rev Cancer"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1001\/jama.294.13.1634","volume":"294","author":"Pasche B.","year":"2005","unstructured":"Pasche B.; Knobloch T.J.; Bian Y.; Liu J.; Phukan S.; Rosman D.; Kaklamani V.; Baddi L.; Siddiqui F.S.; Frankel W.; Prior T.W.; Schuller D.E.; Agrawal A.; Lang J.; Dolan M.E.; Vokes E.E.; Lane W.S.; Huang C.C.; Caldes T.; Di Cristofano A.; Hampel H.; Nilsson I.; von Heijne G.; Fodde R.; Murty V.V.; de la Chapelle A.; Weghorst C.M.; Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA  2005,294(13),1634-1646","journal-title":"JAMA"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-020-01571-5","volume":"39","author":"Lei B.","year":"2020","unstructured":"Lei B.; Wang D.; Zhang M.; Deng Y.; Jiang H.; Li Y.; miR-615-3p promotes the epithelial-mesenchymal transition and metastasis of breast cancer by targeting PICK1\/TGFBRI axis. J Exp Clin Cancer Res  2020,39(1),71","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/nrm2297","volume":"8","author":"Schmierer B.","year":"2007","unstructured":"Schmierer B.; Hill C.S.; TGF&#x3B2;\u2013SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol  2007,8(12),970-982","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/370341a0","volume":"370","author":"Wrana J.L.","year":"1994","unstructured":"Wrana J.L.; Attisano L.; Wieser R.; Ventura F.; Massagu&#xE9; J.; Mechanism of activation of the TGF-&#x3B2; receptor. Nature  1994,370(6488),341-347","journal-title":"Nature"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1002\/ctm2.245","volume":"10","author":"Liu Y.Y.","year":"2020","unstructured":"Liu Y.Y.; Zhang S.; Yu T.J.; Zhang F.L.; Yang F.; Huang Y.N.; Ma D.; Liu G.Y.; Shao Z.M.; Li D.Q.; Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF\u2010&#x3B2;\/Smad signaling to drive breast cancer progression. Clin Transl Med  2020,10(8),e245","journal-title":"Clin Transl Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1016\/j.ejca.2011.07.007","volume":"47","author":"Park C.Y.","year":"2011","unstructured":"Park C.Y.; Son J.Y.; Jin C.H.; Nam J.S.; Kim D.K.; Sheen Y.Y.; EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung. Eur J Cancer  2011,47(17),2642-2653","journal-title":"Eur J Cancer"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3892\/ijo.2019.4879","volume":"55","author":"Wang S.","year":"2019","unstructured":"Wang S.; Huang M.; Wang Z.; Wang W.; Zhang Z.; Qu S.; Liu C.; MicroRNA 133b targets TGF\u2010&#x3B2; receptor I to inhibit TGF\u2010&#x3B2;-induced epithelial to mesenchymal transition and metastasis by suppressing the TGF\u2010&#x3B2;\/SMAD pathway in breast cancer. Int J Oncol  2019,55(5),1097-1109","journal-title":"Int J Oncol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10549-017-4211-y","volume":"163","author":"Wu Y.","year":"2017","unstructured":"Wu Y.; Tran T.; Dwabe S.; Sarkissyan M.; Kim J.; Nava M.; Clayton S.; Pietras R.; Farias-Eisner R.; Vadgama J.V.; A83-01 inhibits TGF-&#x3B2;-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat  2017,163(3),449-460","journal-title":"Breast Cancer Res Treat"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"16552","DOI":"10.1096\/fj.202001448R","volume":"34","author":"Liu W.","year":"2020","unstructured":"Liu W.; Feng M.; Jayasuriya C.T.; Peng H.; Zhang L.; Guan Y.; Froehlich J.A.; Terek R.M.; Chen Q.; Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling. FASEB J  2020,34(12),16552-16566","journal-title":"FASEB J"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/j.1582-4934.2009.00780.x","volume":"14","author":"Li Z.","year":"2010","unstructured":"Li Z.; Kupcsik L.; Yao S.J.; Alini M.; Stoddart M.J.; Mechanical load modulates chondrogenesis of human mesenchymal stem cells through the TGF-&#x3B2; pathway. J Cell Mol Med  2010,14(6a),1338-1346","journal-title":"J Cell Mol Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/ard.2005.045971","volume":"65","author":"Blaney Davidson E.N.","year":"2006","unstructured":"Blaney Davidson E.N.; Vitters E.L.; van der Kraan P.M.; van den Berg W.B.; Expression of transforming growth factor- (TGF) and the TGF signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis  2006,65(11),1414-1421","journal-title":"Ann Rheum Dis"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00280-012-1847-5","volume":"69","author":"Dong M.","year":"2012","unstructured":"Dong M.; Ning Z.Q.; Xing P.Y.; Xu J.L.; Cao H.X.; Dou G.F.; Meng Z.Y.; Shi Y.K.; Lu X.P.; Feng F.Y.; Phase I study of chidamide (CS055\/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas. Cancer Chemother Pharmacol  2012,69(6),1413-1422","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","volume":"69","author":"Ning Z.Q.","year":"2012","unstructured":"Ning Z.Q.; Li Z.B.; Newman M.J.; Shan S.; Wang X.H.; Pan D.S.; Zhang J.; Dong M.; Du X.; Lu X.P.; Chidamide (CS055\/HBI-8000): A new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemother Pharmacol  2012,69(4),901-909","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5582\/irdr.2016.01024","volume":"5","author":"Lu X.","year":"2016","unstructured":"Lu X.; Ning Z.; Li Z.; Cao H.; Wang X.; Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable Rare Dis Res  2016,5(3),185-191","journal-title":"Intractable Rare Dis Res"},{"key":"ref=106","first-page":"802","volume":"17","author":"Gao S.","year":"2017","unstructured":"Gao S.; Li X.; Zang J.; Xu W.; Zhang Y.; Preclinical and clinical studies of chidamide (CS055\/HBI-8000), An orally available subtype-selective HDAC inhibitor for cancer therapy. Anticancer Agents Med Chem  [PMID: 275925462017,17(6),802-812","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.7150\/jca.18762","volume":"8","author":"Lazarova D.","year":"2017","unstructured":"Lazarova D.; Bordonaro M.; ZEB1 mediates drug resistance and EMT in p300-Deficient CRC. J Cancer  2017,8(8),1453-1459","journal-title":"J Cancer"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-018-0988-8","volume":"37","author":"Su Y.","year":"2018","unstructured":"Su Y.; Hopfinger N.R.; Nguyen T.D.; Pogash T.J.; Santucci-Pereira J.; Russo J.; Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors. J Exp Clin Cancer Res  2018,37(1),314","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharmthera.2009.03.001","volume":"122","author":"Tsiftsoglou A.S.","year":"2009","unstructured":"Tsiftsoglou A.S.; Bonovolias I.D.; Tsiftsoglou S.A.; Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy. Pharmacol Ther  2009,122(3),264-280","journal-title":"Pharmacol Ther"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-13-0877","volume":"19","author":"Salvador M.A.","year":"2013","unstructured":"Salvador M.A.; Wicinski J.; Cabaud O.; Toiron Y.; Finetti P.; Josselin E.; Leli&#xE8;vre H.; Kraus-Berthier L.; Depil S.; Bertucci F.; Collette Y.; Birnbaum D.; Charafe-Jauffret E.; Ginestier C.; The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin Cancer Res  2013,19(23),6520-6531","journal-title":"Clin Cancer Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10549-019-05504-5","volume":"179","author":"Hii L.W.","year":"2020","unstructured":"Hii L.W.; Chung F.F.L.; Soo J.S.S.; Tan B.S.; Mai C.W.; Leong C.O.; Histone deacetylase (HDAC) inhibitors and doxorubicin combinations target both breast cancer stem cells and non-stem breast cancer cells simultaneously. Breast Cancer Res Treat  2020,179(3),615-629","journal-title":"Breast Cancer Res Treat"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"605","DOI":"10.21147\/j.issn.1000-9604.2018.06.05","volume":"30","year":"2018","unstructured":"Zhang, Q.; Wang, T.; Geng, C.; Zhang, Y.; Zhang, J.; Ning, Z.; Jiang, Z. Exploratory clinical study of chidamide, an oral subtypeselective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer. Chin. J Cancer Res  2018,30(6),605-612","journal-title":"J Cancer Res"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230508113036","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216640\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230508113036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T16:59:03Z","timestamp":1713373143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216640\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207326666230508113036","relation":{},"ISSN":["1386-2073"],"issn-type":[{"type":"print","value":"1386-2073"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}